마이크로서저리 로봇 시장 기회, 성장 촉진요인, 산업 동향 분석, 예측(2024-2032년)

The Global Microsurgery Robot Market was valued at USD 1.3 billion in 2023 and is projected to grow at a robust CAGR of 13.9% from 2024 to 2032. The market expansion is driven by the rising prevalence of chronic diseases, advancements in surgical technologies, a shortage of skilled surgeons, and favorable reimbursement policies. Increasing demand for precision in high-stakes surgeries boosts the adoption of robotic systems, as these offer enhanced accuracy, improved surgical outcomes, and reduced human error.

The aging global population is another significant factor fueling market growth. Age-related conditions, such as cataracts, cardiovascular diseases, and arthritis, require delicate surgical interventions. Robotic microsurgery systems provide safer, minimally invasive solutions, ensuring better patient recovery and satisfaction.

The market is segmented by application into various categories, including oncology, cardiovascular, neurovascular, reconstructive, and ophthalmology surgeries, among others. Among these, the oncology segment led the market in 2023, generating USD 284.9 million in revenue. Robotic systems in oncology offer unparalleled precision, enabling surgeons to remove cancerous tissues while preserving surrounding healthy tissues. This capability is critical in ensuring clean margins and reducing the risk of cancer recurrence, especially in sensitive anatomical regions.

In terms of end-use, the market is divided into hospitals and clinics, ambulatory surgical centers, research institutes, and other facilities. Hospitals and clinics emerged as the dominant segment in 2023 and are projected to reach USD 2.2 billion by 2032. The adoption of robotic systems in hospitals is driven by their ability to enhance the accuracy and efficiency of complex procedures, such as cardiac, neurosurgical, and oncology operations. Technological advancements, including the integration of AI and data analytics into robotic platforms, are further augmenting their value as healthcare institutions seek to modernize and remain competitive.

North America accounted for USD 737.5 million in revenue in 2023 and is expected to grow at a CAGR of 13.2% during the forecast period. The region's growth is propelled by its aging population, increasing demand for minimally invasive solutions, and a strong private healthcare infrastructure. High investment in cutting-edge technologies by private hospitals and clinics has made North America a frontrunner in adopting microsurgery robots.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing demand for minimally invasive surgical procedures
    • 3.2.1.2 Technological advancements
    • 3.2.1.3 Rising incidences of chronic conditions
    • 3.2.1.4 Increasing funding for development of microsurgery robots in developed countries
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 High cost associated with robotic systems
    • 3.2.2.2 Dearth of skilled healthcare professionals
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Reimbursement scenario
• 3.6 Technology landscape
• 3.7 Porter's analysis
• 3.8 PESTEL analysis
• 3.9 Start-up scenario
• 3.10 Policy outlook
• 3.11 Future market trends
• 3.12 Gap analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
• 4.4 Competitive analysis of major key players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Oncology surgery
• 5.3 Urology surgery
• 5.4 Obstetrics and gynecology surgery
• 5.5 Micro anastomosis
• 5.6 Reconstructive surgery
• 5.7 ENT surgery
• 5.8 Gastrointestinal surgery
• 5.9 Cardiovascular surgery
• 5.10 Ureterorenoscopy
• 5.11 Neurovascular surgery
• 5.12 Ophthalmology surgery
• 5.13 Other applications

Chapter 6 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Hospitals and clinics
• 6.3 Ambulatory surgical centers
• 6.4 Research institutes
• 6.5 Other end users

Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 UK
  • 7.3.3 France
  • 7.3.4 Spain
  • 7.3.5 Italy
  • 7.3.6 Netherlands
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Australia
  • 7.4.5 South Korea
• 7.5 Latin America
  • 7.5.1 Brazil
  • 7.5.2 Mexico
  • 7.5.3 Argentina
• 7.6 Middle East and Africa
  • 7.6.1 South Africa
  • 7.6.2 Saudi Arabia
  • 7.6.3 UAE

Chapter 8 Company Profiles

• 8.1 Asensus Surgical
• 8.2 avateramedical
• 8.3 CMR Surgical
• 8.4 Distalmotion
• 8.5 Intuitive Surgical
• 8.6 Johnson & Johnson (Ethicon)
• 8.7 Medical Microinstruments
• 8.8 Medtronic
• 8.9 meerecompany
• 8.10 MicroSure
• 8.11 Siemens Healthineers
• 8.12 Smith & Nephew
• 8.13 Stryker Corporation
• 8.14 Titan Medical
• 8.15 Zimmer Biomet